Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Non Operating Income (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Non Operating Income for 15 consecutive years, with $570000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income rose 762.79% to $570000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.1 million, a 124.07% decrease, with the full-year FY2024 number at -$1.0 million, down 14542.86% from a year prior.
  • Non Operating Income was $570000.0 for Q3 2025 at Usana Health Sciences, down from $2.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $5.0 million in Q2 2024 to a low of -$8.8 million in Q4 2024.
  • A 5-year average of -$481588.2 and a median of -$86000.0 in 2024 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: crashed 450.36% in 2022, then soared 2077.73% in 2024.
  • Usana Health Sciences' Non Operating Income stood at $139000.0 in 2021, then tumbled by 2185.61% to -$2.9 million in 2022, then crashed by 140.88% to -$7.0 million in 2023, then dropped by 26.29% to -$8.8 million in 2024, then soared by 106.46% to $570000.0 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Non Operating Income are $570000.0 (Q3 2025), $2.4 million (Q2 2025), and $756000.0 (Q1 2025).